Abstract:Myopia has long been a global threat to public health. Timely interventions are likely to reduce the risk of vision-threatening complications. There are both established and rapidly evolving therapeutic approaches to slow myopia progression and/or delay its onset. The effective methods for slowing myopia progression include atropine eye-drops, defocus incorporated multiple segments (DIMS) spectacle lenses, spectacle lenses with highly aspherical lenslets target (HALT), diffusion optics technology (DOT) spectacle lenses, red light therapy (RLT), multifocal soft contact lenses and orthokeratology. Among these, 0.05% atropine, HALT lenses, RLT and +3.00 peripheral addition soft contact lenses yield over 60% reduction in myopia progression, whereas DIMS, DOT and MiSight contact lenses demonstrate at least 50% myopia control efficacy. 0.05% atropine demonstrates a more optimal balance of efficacy and safety than 0.01%. The efficacy of 0.01% atropine has not been consistent and requires further validation across diverse ethnicities. Combining atropine 0.01% with orthokeratology or DIMS spectacles yields better outcomes than using these interventions as monotherapies. Increased outdoor time is an effective public health strategy for myopia prevention while recent studies suggest that 0.05% low-concentration atropine and RLT therapy have promising potential as clinical myopia prevention interventions for high-risk groups. Myopia control spectacle lenses, being the least invasive, are safe for long-term use. However, when considering other approaches, it is essential to ensure proper instruction and regular follow-ups to maintain safety and monitor any potential complications. Ultimately, significant advances have been made in myopia control strategies, many of which have shown meaningful clinical outcomes. However, regular use and adequate safety monitoring over extended durations are imperative to foster confidence that can only come from extensive clinical experience.

New angle of view of traditional chinese medicine orientation and innovation and development of myopia prevention and control in teenagers

Current Situation and Thinking of Prevention and Control of Myopia among Children and Adolescents in China

Study on Prevention and Control Measures of Adolescent Myopia based on Myopia Health Education

Clinical Observation on the Prevention and Treatment of Juvenile Mild Myopia with Traditional Chinese Medicine Comprehensive Therapy

Vision for the future: pioneering strategies in China's battle against myopia

[The Key Points of Chinese Children Myopia Prevention and Control].

Chinese Parents' Perspective on Myopia: A Cross-Sectional Survey Study

Advances in myopia control strategies for children

[Chinese expert consensus on comprehensive public health intervention for myopia prevention and control in children and adolescents]

Investigation of the Associated Factors Leading to Myopia in Five Primary School Students in Hangzhou

The Research on the Paths of Popular Science Education about Myopia Prevention and Control among College Students in the Context of Shifting the Focus Forward

[Epidemiology of high myopia among children and adolescents in China].

The Increasing Prevalence of Myopia and High Myopia among High School Students in Fenghua City, Eastern China: a 15-Year Population-Based Survey

Improving myopia awareness via school-based myopia prevention health education among Chinese students

IMI Prevention of Myopia and Its Progression

Developmental characteristics and control effects of myopia and eye diseases in children and adolescents: a school-based retrospective cohort study in Southwest China

Analysis and modeling of myopia-related factors based on questionnaire survey

Trends in myopia development among Chinese children and adolescents in Xuzhou during one academic year

Epidemiology of Myopia

Review of Risk Factors and Intervention of Myopia in Children and Adolescents